The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria T Zuberbier, W Aberer, R Asero, AH Abdul Latiff, D Baker, ... Allergy 73 (7), 1393-1414, 2018 | 3862* | 2018 |
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria T Zuberbier, R Asero, C Bindslev‐Jensen, G Walter Canonica, MK Church, ... Allergy 64 (10), 1427-1443, 2009 | 1222* | 2009 |
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria M Maurer, K Rosén, HJ Hsieh, S Saini, C Grattan, A Gimenéz-Arnau, ... New England Journal of Medicine 368 (10), 924-935, 2013 | 1186 | 2013 |
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1 M Maurer, K Weller, C Bindslev‐Jensen, A Giménez‐Arnau, PJ Bousquet, ... Allergy 66 (3), 317-330, 2011 | 1007 | 2011 |
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria T Zuberbier, R Asero, C Bindslev‐Jensen, G Walter Canonica, MK Church, ... Allergy 64 (10), 1417-1426, 2009 | 862 | 2009 |
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study SS Saini, C Bindslev-Jensen, M Maurer, JJ Grob, EB Baskan, MS Bradley, ... Journal of Investigative Dermatology 135 (1), 67-75, 2015 | 529 | 2015 |
Omalizumab-induced reductions in mast cell FcεRI expression and function LA Beck, GV Marcotte, D MacGlashan Jr, A Togias, S Saini Journal of Allergy and Clinical Immunology 114 (3), 527-530, 2004 | 526 | 2004 |
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria S Saini, KE Rosen, HJ Hsieh, DA Wong, E Conner, A Kaplan, S Spector, ... Journal of Allergy and Clinical Immunology 128 (3), 567-573. e1, 2011 | 504 | 2011 |
Diagnosis and treatment of urticaria and angioedema: a worldwide perspective M Sánchez-Borges, R Asero, IJ Ansotegui, I Baiardini, JA Bernstein, ... World Allergy Organization Journal 5, 125-147, 2012 | 303 | 2012 |
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria AP Kaplan, AM Giménez‐Arnau, SS Saini Allergy 72 (4), 519-533, 2017 | 277 | 2017 |
Down-regulation of human basophil IgE and FCεRIα surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo SS Saini, DW MacGlashan, SA Sterbinsky, A Togias, DC Adelman, ... The Journal of Immunology 162 (9), 5624-5630, 1999 | 259 | 1999 |
Occupational rhinitis EAACI Task Force on Occupational Rhinitis, G Moscato, O Vandenplas, ... Allergy 63 (8), 969-980, 2008 | 219 | 2008 |
Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients LK DeLong, SD Culler, SS Saini, LA Beck, SC Chen Archives of Dermatology 144 (1), 35-39, 2008 | 196 | 2008 |
Chronic spontaneous urticaria: etiology and pathogenesis SS Saini Immunology and Allergy Clinics 34 (1), 33-52, 2014 | 194 | 2014 |
Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy JH Savage, JP Courneya, PM Sterba, DW MacGlashan, SS Saini, ... Journal of allergy and clinical immunology 130 (5), 1123-1129. e2, 2012 | 183 | 2012 |
Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. PD Smith, SS Saini, M Raffeld, JF Manischewitz, SM Wahl The Journal of clinical investigation 90 (5), 1642-1648, 1992 | 182 | 1992 |
Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies JA Eckman, RG Hamilton, LM Gober, PM Sterba, SS Saini Journal of investigative dermatology 128 (8), 1956-1963, 2008 | 181 | 2008 |
TLR9-and FcεRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression JT Schroeder, AP Bieneman, HQ Xiao, KL Chichester, K Vasagar, S Saini, ... The Journal of Immunology 175 (9), 5724-5731, 2005 | 170 | 2005 |
New concepts in chronic urticaria BM Vonakis, SS Saini Current opinion in immunology 20 (6), 709-716, 2008 | 160 | 2008 |
Granulocyte-Macrophage Colony-Stimulating Factor Augments Human Monocyte Fungicidal Activity for Candida albicans PD Smith, CL Lamerson, SM Banks, SS Saini, LM Wahl, RA Calderone, ... Journal of Infectious Diseases 161 (5), 999-1005, 1990 | 157 | 1990 |